
Journal of the American Chemical Society p. 8724 - 8736 (1991)
Update date:2022-08-04
Topics:
Fryzuk, Michael D.
Joshi, Kiran
Chadha, Raj K.
Rettig, Steven J.
The thermal and photolytic transformations of a series of methyliridium(III) phosphide complexes are described. Complexes of the formula Ir(CH3)PR2[N(SiMe2CH2PPh 2)2] (R = Ph, Me) rearrange thermally to generate the corresponding cyclometalated derivatives fac-Ir(η2-CH2PR2)H[N(SiMe 2CH2PPh2)2]; continued thermolysis results in the formation of the iridium(I) phosphine complexes Ir(PMeR2)[N(SiMe2CH2PPh2) 2]. Under photolytic conditions the phosphide derivatives rearrange directly to the phosphine complexes with no observable intermediates. The phenylphosphide complex Ir(CH3)PHPh[N(SiMe2CH2PPh2) 2] rearranges directly to the phosphine derivative Ir(PHPhMe)[N(SiMe2CH2PPh2)2] both thermally and photolytically with no observable intermediates. Crystals of Ir(CH3)PPh2[N(SiMe2CH2PPh 2)2] are monoclinic with a = 13.506 (3) A?, b = 13.665 (3) A?, c = 22.816 (7) A?, β= 92.35 (2)°, Z = 4, Dc = 1.454 g cm-3, and space group P21/c. The structure was solved by the Patterson method and refined by full-matrix least-squares procedures to R = 0.034 and Rw = 0.037 for 3993 reflections with I ≥ 3σ(I). Crystals of fac-Ir(η2-CH2PPh2)H[N(SiMe 2CH2PPh2)2] are monoclinic with a = 9.253 (2) A, b = 21.950 (5) A?, c = 20.081 (4) A?, β= 90.74 (2)°, Z = 4, Dc = 1.50 g cm-3, and space group P21/c. The structure was solved by conventional heavy-atom techniques and was refined in blocks (with the Ir atom in every cycle) by using least-squares procedures down to R = 0.0356 and Rw = 0.0370 for 4448 reflections with I ≥ 3σ(I). Mechanistic studies showed that the formation of the cyclometalated hydride does not involve reductive transfer of the methyl and the phosphide ligands to form a phosphine complex followed by intramolecular C-H bond activation, rather C-H bond abstraction occurs first followed then by C-P bond formation. Transition-state arguments are used to rationalize the difference in the reactivity of the phenylphosphide complex for which no cyclometalated intermediate was detected.
Xinchang Jiu Xin Pharmaceutical Co., Ltd
website:http://www.jiuxinpharm.com
Contact:86 137 5756 8585
Address:Poyang industry Park
Suzhou Chiral Pharmaceuticals Co., Ltd.
Contact:86-0512-63197058
Address:Building A, No. 2358, Chang'an Road, Wujiang Science Park
ShangHai Soyoung Biotechnology Inc
website:http://www.soyoungbio.com
Contact:+86-21-69893009
Address:shanghai
Shanghai Rich Chemicals Co., Ltd
website:http://www.richchemical.com
Contact:+86-21-20255798
Address:Pudong Shanghai,China
Heliosense Biotechnologies, Inc.
website:https://www.heliosense.com/
Contact:+86-592-5667290
Address:Xiamen Torch Hi-tech Zone Venture Weiye Building S506
Doi:10.1016/j.ejmech.2012.01.054
(2012)Doi:10.1021/jo991418m
(2000)Doi:10.1021/ja301184r
(2012)Doi:10.1002/hlca.19910740612
(1991)Doi:10.14233/ajchem.2014.15987
(2014)Doi:10.1002/anie.201609255
(2016)